New research into the biology of depression, along with new and evolving technologies, provides the basis for developing the next generation of treatments for major depressive disorder (MDD), according to the special January/February issue of Harvard Review of Psychiatry. “By embracing a multifactorial understanding of MDD, by attending carefully to the sex difference in its prevalence and manifestation, and by […]